LWMI
UTHR icon

Legacy Wealth Management (Idaho)’s United Therapeutics UTHR Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-103
Closed -$61.1K – 922
2026
Q1 		$61.1K Buy
103
+3
+3% +$1.49K 0.03% 243
2025
Q4 		$48.7K Buy
100
+74
+285% +$34.5K 0.02% 221
2025
Q3 		$10.9K Hold
26
– – ﹤0.01% 333
2025
Q2 		$7.47K Sell
26
-7
-21% -$2.09K ﹤0.01% 352
2025
Q1 		$10.2K Hold
33
– – 0.01% 324
2024
Q4 		$11.5K Buy
33
+7
+27% +$2.57K 0.01% 264
2024
Q3 		$10.4K Buy
+26
New +$8.78K 0.01% 306

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Legacy Wealth Management (Idaho)'s UTHR Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 103 shares — an estimated $61.1K sold.

Legacy Wealth Management (Idaho) first reported a position in UTHR in Q3 2024 and held it in 7 quarters. The position peaked at $61.1K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 103 United Therapeutics shares in Q2 2026, an estimated $61.1K.
  • Legacy Wealth Management (Idaho) first reported a position in United Therapeutics in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s United Therapeutics position peaked at $61.1K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.